The News-Gazette, a publication serving Illinois, reports on Prenosis securing a deal for its AI-driven sepsis diagnostic tool, the Sepis ImmunoScore™:
CHICAGO — A biotech company with local roots has landed a distribution deal for its AI tool for sepsis diagnosis, with the news coming just one week after the technology received authorization from the Food and Drug Administration.
Prenosis, which is based in Chicago, has announced that it will work with Roche Diagnostics to bring its Sepsis ImmunoScore tool to hospitals across the country. The technology is the first AI tool for sepsis diagnosis to receive marketing authorization from the FDA, the company said.
“They (Roche) have thousands of sales representatives across the United States and deep relationships with many of these hospitals, and so they can really help us get it out there and get to save as many patients as possible as quickly as possible,” said Prenosis CEO Bobby Reddy Jr., a University of Illinois Urbana-Champaign alum who co-founded the company alongside Rashid Bashir, dean of the Grainger College of Engineering.
According to the Centers for Disease Control and Prevention, sepsis is a “life-threatening medical emergency” that occurs when the body has an “extreme response” to an infection.
“In a typical year, at least 1.7 million adults in America develop sepsis and at least 350,000 adults who develop sepsis die during their hospitalization or are moved into hospice care,” the CDC reported.
Roche vetted several sepsis algorithms before choosing Sepsis ImmunoScore as its exclusive partner for a five-year distribution contract, Prenosis officials said. Sepsis ImmunoScore will be available on Roche’s navify Algorithm Suite platform.
The diagnostic tool uses lab-based biomarkers, clinical data and AI to evaluate a patient’s likelihood of having or developing sepsis within 24 hours of assessment.
Prenosis has spent 10 years working with hospital systems to build a proprietary biobank, dataset and Immunix precision medicine platform that led to the development of Sepsis ImmunoScore.
According to Reddy, the first hospital they worked with to build this collection was Carle Foundation Hospital.
Read the article here.